Revance Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Revance Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Revance Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$38.1M, a 73% increase year-over-year.
  • Revance Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$184M, a 55.5% increase year-over-year.
  • Revance Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$324M, a 9.1% increase from 2022.
  • Revance Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$356M, a 26.7% decline from 2021.
  • Revance Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$281M, a 0.28% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$324M +$32.4M +9.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$356M -$75.1M -26.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$281M +$779K +0.28% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$282M -$123M -76.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$159M -$16.9M -11.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$143M -$22M -18.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$121M -$31.3M -35.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$89.3M -$15.8M -21.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$73.5M -$10.6M -16.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
2014 -$62.9M -$10.5M -20% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$52.4M -$20.2M -62.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 -$32.2M +$12.7M +28.2% Jan 1, 2012 Dec 31, 2012 10-Q 2015-08-07
2011 -$44.9M -$15.6M -53.5% Jan 1, 2011 Dec 31, 2011 10-Q 2014-05-14
2010 -$29.2M Jan 1, 2010 Dec 31, 2010 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.